Clinical Trials Browser

Solid Tumors × Axitinib × Clear all

NCT00828919 2024-12-03

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Phase NA Completed

52 enrolled 12 charts

Other solid neoplasm

Solid Tumors

NCT02354612 2021-02-15

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

No longer available

Other solid neoplasm

Solid Tumors